The ASAM Pain & Addiction Essentials Online- Module 1: The Science of Pain & Addiction

4.67 (3 votes)

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $19
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29

image

Module Overview


Module 1: The Science of Pain & Addiction is an interactive, fully online 1.5-hour module designed for providers who are relatively new to the field of pain and addiction medicine. This course is designed for providers such as primary care physicians, fellows in training and residents, providers who are new to addiction medicine or are early in their career and other members of the care team who are looking for introductory topics on pain and addiction. 

This module is part of The ASAM Pain & Addiction Essentials, a series of 6 online modules (rolled out throughout 2021) that cover the foundations of pain and addiction including the science, stigma, screening and assessment, treatment, and interdisciplinary approaches. All modules can be taken together as a full 6-hour course or can be taken individually to fill learner knowledge gaps in pain and addiction topics. 

Learners looking for more advanced topics in pain and addiction should register for The ASAM Pain & Addiction: Common Threads Course which takes place annually. 

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  1. Understand the neurobiology and physiology of addiction and considerations in treatment 
  2. Understand the neurobiology, physiology, and diagnosis of pain and considerations in treatment 
  3. Identify protective and risk factors related to the development of addiction and chronic pain
  4. Describe the pharmacology of common drugs (including medications used in treatment as well as substances with potential for misuse) and the impact of these drugs on pain and addiction 

This module is worth a total of 1.5 AMA PRA Category 1™ Credits.

Key:

Complete
Failed
Available
Locked
Module 1: The Science of Pain & Addiction
Begin self-paced component package.
Begin self-paced component package. Complete Module 1 by clicking the View Course button. This module will take between 60-90 minutes to complete and includes videos, text, activities, and knowledge check questions.
Complete the CME Quiz
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete this quiz with 70% accuracy to claim your CME.
Complete Module Evaluation
17 Questions
17 Questions Please complete the evaluation of the module to claim CME.
Download CME Certificate
Up to 1.50 medical credits available  |  Certificate available
Up to 1.50 medical credits available  |  Certificate available This product is worth a total of 1.5 AMA PRA Category 1™ Credits.

Donald R. Teater

MD, MPH

Don Teater MD, MPH is a family physician who has worked in western North Carolina for the past 30 years. Since 2004 he has focused on the intersection of pain, opioids, and addiction. Don was the lead facilitator for the expert panel during the development of the CDC Guidelines for Prescribing Opioids for Chronic Pain.

From 2013-2016, Don was the Medical Advisor at the National Safety Council leading their effort to reduce opioid abuse and overdose in the community and in the workplace. He continues to work with federal and state government organizations, medical organizations and nonprofits in addressing many aspects of the opioid epidemic.

While working on the public health aspects of the opioid epidemic, he sees patients one day a week treating opioid use disorder and chronic pain in Waynesville, NC by telemedicine. He also works one week each month as a pain and addiction specialist seeing Alaska Native patients with the SouthEast Alaska Regional Health Consortium (SEARHC) in Juneau, AK.

Maureen Boyle

PhD

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) where she oversees ASAM’s quality improvement programs, publication development, and science initiative with the goal of supporting effective implementation of evidence based practices in the addiction treatment system.

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Dr. Boyle has worked in the areas of  research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), and the National Institute on Drug Abuse (NIDA).  At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan; she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public; and she led development of research reports and other science communication materials. 

Launette Marie Rieb

MD, MSc, CCFP, FCFP, DABAM, FASAM

Launette Rieb, MD, MSc, CCFP, FCFP, DABAM, FASAM is a Clinical Associate Professor in the Department of Family Practice at the University of British Columbia (UBC), Canada. She is a Family Physician and diplomat of The American Board of Addiction Medicine. She did her graduate work in the area of pain physiology. She completed a postgraduate UBC Clinical Scholar's Program in 2015 and a NIDA sponsored Canadian Addiction Medicine Research Fellowship in 2016 resulting in publication on a newly described opioid pain phenomenon - withdrawal-associated injury-site pain (WISP). She has also published on fentanyl and heroin overdose deaths in BC, as well as on addiction in a variety of marginalized populations. Dr. Rieb is the Medical Director of a multidisciplinary team at OrionHealth (Vancouver Pain Clinic), and works as a consultant for the Rapid Access Addictions Clinic at St. Paul’s Hospital in Vancouver. In addition, she does addiction medicine consultations for The Orchard Recovery Centre, on Bowen Island. Dr. Rieb has taught addiction medicine in the undergraduate and postgraduate medical programs at UBC, and at national and international conferences for 24 years. Dr. Rieb was the co-creator and initial Physician Director of the St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship (now the BC Centre on Substance Use Addiction Medicine Fellowship). She is a member of the Canadian Society of Addiction Medicine’s Education Committee and the College of Family Physician of Canada's Competency Creation Working Group for the Certificate of Added Competency in Addiction Medicine. Dr. Rieb is the past recipient of a UBC Faculty of Medicine Post Graduate Teaching Award. 

No relevant financial disclosures.

Credits and Disclosures


ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification


American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credit towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1.5 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

Royal College of Physicians and Surgeons of Canada (RCPSC)

Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

CME Reviewer and Disclosure Information


ASAM CME Committee Reviewer

Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Faculty and Planning Committee


Faculty Disclosure Information

Donald R. Teater, MD, MPH – No Relevant Financial Disclosures 
Denver, CO

Maureen Boyle, PhD – No Relevant Financial Disclosures 
Rockville, MD

Launette Marie Rieb, MD, MSc, CCFP, FCFP, FASAM – No Relevant Financial Disclosures
Vancouver, BC


Planning Committee Disclosure Information

William S. Jacobs, MD (Chair) – No Relevant Financial Disclosures
Saint Johns, FL

Gregory Rudolf, MD (Vice-Chair) – No Relevant Financial Disclosures
Seattle, WA

Mark Weiner, MD, DFASAM (Immediate Past Chair) – No Relevant Financial Disclosures
Ann Arbor, MI

Harithsa S. Asuri, MD – No Relevant Financial Disclosures
Cincinnati, OH

Gregory X. Boehm, MD, DFASAM – No Relevant Financial Disclosures
Shaker Heights, OH

Denise Josey, MD, MPH, MS – No Relevant Financial Disclosures
Lake Worth, FL

Laura Morgan Frankart, PharmD, MEd, BCPS – No Relevant Financial Disclosures
Richmond, VA

Launette Marie Rieb, MD, MSc, CCFP, FCFP, FASAM – No Relevant Financial Disclosures
Vancouver, BC

Donald R. Teater, MD, MPH – No Relevant Financial Disclosures 
Denver, CO

Michael P. Sprintz, DO, DFASAM – Dose Disclose 
Shenandoah, TX

  • Cellarian, Inc, Clinical Condition: Diagnostic Toxicology, SUD, COVID-19, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property)
  • FirsTox, LLC, Clinical Condition: Drug Testing, Consultant/Advisory Board, Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  • Saluda Medical, Clinical Condition: Pain Management, Consultant/Advisory Board
  • Mahantech, Clinical Condition: PDMP for SUD identification, Consultant/Advisory Board
  • Dean Law firm, Clinical Condition: Pain management, Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  • Texas Pain Society, Clinical Condition: Pain and addiction, Speaker honoraria
  • Texas A&M University Health Center, Clinical Condition: Pain and addiction, Speaker honoraria

All relevant financial relationships have been mitigated